Affiliation:
1. E.N. Meshalkin National Medical Research Center, Ministry of Health of Russia
2. Oncology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Abstract
An indicator of the effectiveness of treatment of cancer patients, in addition to oncological results, is also the preservation of their quality of life. Quality of life assessment is a modern research method that allows identifying even minor changes in any spheres of human activity in order to comprehensively determine the effectiveness of treatment. The quality of life of cancer patients is a priority and promising area of modern medicine.The article presents information about the current state of the problem of quality of life of patients with cervical cancer after organ-preserving treatment. The results of a number of foreign studies published on this topic are presented. In addition, the results of a prospective study conducted in the Department of Gynecology of the Tomsk Oncology Research Institute are presented. In conclusion, the need for additional study of reproductive results and determining which factors need to be further evaluated, speaking of a comprehensive assessment, is shown.
Publisher
Publishing House ABV Press
Reference34 articles.
1. State of oncological care in Russia in 2022. Eds.: А.D. Kaprin, V.V. Starinskiy, A.O. Shachzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2022. 239 p. (In Russ.).
2. Li C. Quality of life in long-term survivors of cervical cancer. Maturitas 1999;32(2):95–102.
3. Bonomi A.E., Cella D.F., Hahn E.A. et al. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) Quality of Life Measurement System. Qual Life Res 1996 5:1–12.
4. Giesler R.B., Williams S.D. Opportunities and challenges: Assessing quality of life in clinical trials. J Natl Cancer Inst 1998;90(20):1498, 1499.
5. Kaasa S., Knobel H., Loge J.H., Hjermstad M.J. Hodgkin’s disease: Quality of life in future trials. Ann Oncol 1998;9(5 Suppl):137–45.